BioCentury
ARTICLE | Clinical News

Binimetinib regulatory update

July 11, 2016 7:00 AM UTC

Array submitted an NDA to FDA for binimetinib to treat advanced neuroblastoma Ras viral (v-Ras) oncogene (NRAS) mutation-positive melanoma. Binimetinib is a small molecule selective MAP kinase kinas...